Published by ChinaMNC · Lincang

Yunnan's 15th Five-Year Plan for Traditional Chinese Medicine Materials: Key Takeaways for Foreign Founders

Yunnan Province has released its 2030 plan for the traditional Chinese medicine (TCM) materials industry, aiming to reduce planting area while increasing output value. For foreign founders, this signals opportunities in high-quality TCM production, processing, and technology—but also regulatory considerations for company registration and operations in China.

What the Plan Means for Your China Company Registration

Yunnan Province’s new plan for TCM materials (2026–2030) sets clear targets: by 2030, the planting area is expected to decrease by 1.608 million mu, while the comprehensive output value is targeted to increase by 50 billion yuan. The strategy is to trade area for quality, processing, branding, and efficiency. For foreign founders looking to enter China’s TCM sector, this plan outlines priority varieties, production standards, and support mechanisms that can inform your business scope and location choices.

1. Priority Varieties and Product Focus

Building on the 156 varieties listed in the 2024 Yunnan Dao-di Medicinal Materials Catalogue, the plan prioritizes three categories:

• Dao-di advantage varieties: The “Top Ten Yunnan Medicines,” represented by Panax notoginseng (Sanqi), including Yunnan Paris polyphylla, Erigeron breviscapus, Dendrobium officinale, Amomum villosum, Gastrodia elata, Yunnan Poria, Yunnan Angelica sinensis, Yunnan Aucklandia lappa, and Yunnan Gentiana.
• Health-characteristic varieties: The “Top Ten Health Resources,” such as Polygonatum kingianum, Carthamus tinctorius, Bletilla striata, Dendrobium devonianum, Phyllanthus emblica, Coix seed, Terminalia chebula, Amomum tsaoko, ginger, and star anise.
• Potential cultivation varieties: The “Six Southern Medicines,” including Amomum villosum, Dragon’s blood, Cibotium barometz, Aquilaria sinensis, Orthosiphon aristatus, and Dai Bai Jie.

For your China company: When defining your business scope, consider focusing on these priority varieties. They are likely to receive policy support and easier access to resources. If you plan to register a company in Yunnan, aligning with these categories can strengthen your application for local incentives.

2. Standardized Production: GAP Bases

The plan aims to build 200 GAP (Good Agricultural Practice) bases for TCM materials, with a key focus on full coverage of Sanqi GAP bases in Wenshan. It also promotes GAP bases for under-forest varieties such as Poria, Amomum villosum, Amomum tsaoko, and Phellodendron chinense, and seeks to create national-level high-standard raw material production bases.

For your China company: If your business involves cultivation or sourcing, partnering with or establishing GAP bases can enhance product quality and compliance. Foreign invested enterprises (FIEs) may participate in such projects, but be aware that agricultural land use and planting may require additional approvals. Consulting local authorities during registration is advised.

3. Under-Forest Cultivation and Ecological Planting

Focusing on Dao-di herbs like Sanqi, Gastrodia, Poria, Amomum villosum, Polygonatum, and Phellodendron, the plan expands ecological and under-forest cultivation bases to over 6 million mu.

For your China company: This expansion offers opportunities in sustainable sourcing and supply chain integration. If you register a company engaged in under-forest planting, check local regulations on forest land use and environmental impact assessments.

4. Primary Processing and Product Upgrading

The plan supports establishing primary processing lines in Dao-di production areas and high-standard raw material bases. It promotes linking GAP base materials with fresh-cut processing and upgrading products from raw materials to semi-industrialized inputs.

For your China company: Setting up processing facilities requires compliance with Chinese Good Manufacturing Practice (GMP) and food safety standards. When registering, ensure your business scope includes processing and obtain necessary licenses from provincial drug and food authorities.

5. High-Value-Added Products and Deep Processing

Enterprises are encouraged to build modern deep-processing lines, develop high-value-added products, and create a series of Yunnan medicine health products. The plan also promotes R&D and industrialization of health products such as daily cosmetics and functional wellness items.

For your China company: This is a key area for foreign investment. You may consider registering a wholly foreign-owned enterprise (WFOE) or a joint venture (JV) with a scope covering R&D, production, and sales of health products. Note that cosmetics and health foods require separate registrations with the National Medical Products Administration (NMPA).

6. Market Stabilization and Risk Prevention

The plan aims to stabilize markets for bulk varieties like Sanqi, Angelica, and Paris polyphylla through market-based adjustments, and to build an information monitoring and early-warning system to prevent risks such as blind expansion and price collapses.

For your China company: This suggests increased market transparency and reduced volatility, which can benefit long-term planning. However, foreign investors should monitor policy changes and maintain compliance with price monitoring and reporting requirements.

7. Food-Medicine Homology Development

The plan includes developing standards for food-medicine homology raw materials and processing, completing cross-border registration for 5–10 new products, and planning a “Yunnan Medicine Food-Medicine Homology Cultural Festival.”

For your China company: Food-medicine homology products are subject to strict classification. If you plan to produce or sell such products, ensure your company registration includes food production and sales, and obtain relevant permits. Cross-border registration may involve additional procedures with customs and market regulators.

8. “Yunnan Medicine Brain” AI Initiative

An AI innovation project, the “Yunnan Medicine Brain,” will build an intelligent application system covering the entire lifecycle of TCM materials, focusing on multi-level, multi-scenario solutions.

For your China company: This digitalization trend may create opportunities for tech-enabled ventures. Foreign founders in AI or data analytics could explore partnerships or register a technology company to participate in such projects, but be mindful of data security and cross-border data transfer rules.

Practical Steps for Foreign Founders

To capitalize on these opportunities, consider the following when registering your China company:

• Entity choice: A WFOE is common for wholly foreign-owned operations; a JV may be required for certain restricted sectors. Check the Negative List for foreign investment.
• Business scope: Clearly define activities related to TCM planting, processing, R&D, and sales. Some activities require pre-approval.
• Registered capital: No minimum for most companies, but consider capital needs for licensing and operations.
• Documents: Prepare notarized and apostilled incorporation documents, passport copies, and proof of address.
• Licenses: Obtain industry-specific permits (e.g., drug production, food production) from provincial authorities.
• Tax and compliance: Understand corporate income tax, VAT, and local incentives. Engage a local accountant.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.

For assistance with registering and operating a company in China, foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535.